课题基金 / 基金详情

PREDNISONE PHARMACOKINETICS IN JUVENILE DERMATOMYOSITIS

PREDNISONE PHARMACOKINETICS IN JUVENILE DERMATOMYOSITIS
泼的松在青少年皮肌炎中的药代动力学
批准号:
7604233
负责人:
LAUREN M. PACHMAN
金额:
$0.27万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30

项目摘要

项目成果

LAUREN M. PACHMAN的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得主要资金, 因此可以在其他CRISP条目中表示。列出的机构是 研究中心,而研究中心不一定是研究者所在的机构。 某些结缔组织病患儿的超敏性血管炎的特征是血液中新蝶呤和血管性血友病因子抗原水平升高。 活动性血管炎与炎症(通过增加的巨噬细胞衍生的新蝶呤水平测量)和/或内皮细胞损伤(通过增加的血管性血友病因子抗原测量)相关。 皮质类固醇是许多儿科风湿性疾病的首选药物,这些疾病具有血管炎的成分,但关于给药途径存在争议。 本研究的目的是确定活动性血管炎是否与口服泼尼松龙吸收的生物利用度降低有关,与静脉注射(甲泼尼龙)时获得的值相比。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Hypersensitivity vasculitis in some children with connective tissue disease is characterized by increased blood levels of neopterin and von Willebrand factor antigen. Active vasculitis is associated with inflammation (measured by increased macrophage derived neopterin levels) and/or endothelial cell damage (measured by increased von Willebrand factor antigen). Corticosteroids are the drugs of choice for many pediatric rheumatic diseases, which have a component of vasculitis, but there is controversy concerning the route of administration. The purpose of this study is to ascertain if active vasculitis is associated with decreased bioavailability of absorption of oral prednisolone when compared with values obtained when this substance is given by the intravenous route (methylprednisolone).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identical Twins Discordant for Juvenile Dermatomyositis: iPSC-Myogenic Cells
Disease chronicity in juvenile dermatomyositis (JDM): Epigenetic clues
Disease chronicity in juvenile dermatomyositis (JDM): Epigenetic clues
Disease chronicity in juvenile dermatomyositis (JDM): Epigenetic clues
海外基金